| TPBC | Triple-Positive Breast Cancer |
| ER | Estrogen Receptor |
| PR | Progesterone Receptor |
| HER2 = EGFR2 | Human Epidermal Growth Factor Receptor 2 |
| BC | Breast cancer |
| NCCN | National Comprehensive Cancer Network |
| NCBI | National Center for Biotechnology Information |
| EGFR = HER1 | Epidermal Growth Factor Receptor |
| HER3 | Human Epidermal Growth Factor Receptor 3 |
| HER4 | Human Epidermal Growth Factor Receptor 4 |
| PI3K | phosphatidylinositol 3-kinase |
| AKT | a serine/threonine protein kinase |
| mTOR | [Ser/Thr kinase] mechanistic target of rapamycin |
| MAPK | mitogen-activated protein kinases |
| ERK | Extracellular Signal-Regulated Kinase |
| ErbB | Erythroblastic Leukemia Viral Oncogene Homolog [family] |
| ADCC | Antibody-dependent cytotoxicity |
| Fc-mediated immunity | Constant fragment [of antibodies that mediates downstream effector functions via its interaction with Fc-receptors on (innate) immune cells] |
| CDK4 | Cyclin-Dependent Kinase 4 |
| TGF-α | Transforming Growth Factor Alpha |
| EGF | Epidermal Growth Factor |
| Met | methionine |
| BIRC5 | baculoviral inhibitor of apoptosis repeat-containing 5 |
| TRAF4 | Tumor Necrosis Factor Receptor-Associated Factor 4 |
| PTEN | Phosphatase and Tensin homolog |
| PIK3CA | gene encodes for the p110 alpha (p110α) protein, catalytic subunit of PI3K |
| CD55 | Decay-accelerating factor (CD55 = DAF) |
| CD59 | [Protective protein] |
| Wnt3 | Wnt refers to a family of secreted signaling proteins involved in various biological processes, particularly in cell communication and development. The name “Wnt” is a portmanteau derived from “Wingless”, a gene from the fruit fly Drosophila, and “Int-1”, a proto-oncogene from mice. |
| PDGFRA | gene encodes for PDGFRα |
| PDGFRα | platelet-derived growth factor receptor alpha |
| MUC1-C | C-terminal subunit for MUC1 protein |
| IGF-1R | Insulin-like Growth Factor 1 Receptor |
| P85β | regulatory subunit of PI3K |
| P110 | isoforms of the class-1A PI3K signaling pathway |
| Yes1 | non-receptor protein tyrosine kinase |
| Src | non-receptor protein tyrosine kinase |
| OXPHOS | Oxidative Phosphorylation |
| NDUFA4L2 | NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 |
| ROS | Reactive Oxygen Species |
| LMO4 | LIM Domain Only 4 |
| YB-1 | Y-box Binding Protein 1 |
| CD44 | Cluster of Differentiation 44 |
| IL6 | Interleukin-6 |
| BCL-2 | B-cell Lymphoma 2 |
| P95her2 | Truncated HER2 receptor (p95HER2) |
| HERA program | HERceptin Adjuvant trial |
| AXL | AXL Receptor Tyrosine Kinase |
| GSK3 | Glycogen Synthase Kinase 3 |
| mTOR-C1 | mTOR complex 1 |
| Wnt | Wingless/Integrated |
| NFGR | Nerve Growth Factor Receptor |
| MUSK | Muscle-Specific Kinase |
| VEGFR1 | Vascular Endothelial Growth Factor Receptor 1 |
| PDGFRA | Platelet-Derived Growth Factor Receptor Alpha |
| PDGFβ | Platelet-Derived Growth Factor Beta |
| EPHA2 | Ephrin Type-A Receptor 2 |
| EPHB2 | Ephrin Type-B Receptor 2 |
| Fak = FAK1 | Focal adhesion kinase 1 |
| PBC | primary breast cancer |
| SERMs | Selective Estrogen Receptor Modulators |
| MUC1 | Mucin-1 |
| AIB1 | Amplified in Breast Cancer 1 (SRC-3) |
| SERD | Selective Estrogen Receptor Degrader |
| CXXC4 | CXXC Finger Protein 4 |
| PBCC | primary basal cell carcinoma |
| MED1 | Selective Estrogen Receptor Degrader |
| Eph | Eph receptors |
| AKT1 | AKT Serine/Threonine Kinase 1 |
| CSC | cancer stem cells |
| TGF-β | Transforming Growth Factor Beta |
| STAT3 | Signal transducer and activator of transcription 3 |
| NF-kB | Nuclear Factor kappa B |
| SMAD | Transcription factors proteins for TGF-β. SMAD is a portmanteau from SMA (small body size) and MAD (Mothers Against Decapentaplegic). |
| AURKA | Aurora kinase A |
| TrkB | Tropomyosin Receptor Kinase B |
| SOX2 | SRY-Box Transcription Factor 2 |
| CD24 | Cluster of Differentiation 24 |
| MHC | Major Histocompatibility Complex |
| HLA | Human Leukocyte Antigen |
| CD4/6 | Cyclin-Dependent Kinases 4/6 |
| AI | artificial intelligence |
| KEEG | Kyoto Encyclopedia of Genes and Genomes (KEGG) |
| hsa:2064 | Human gene identifier (ERBB2/HER2) |
| JAK | Janus Kinase |
| TKI | tyrosine kinase inhibitors |
| EMT | epithelial–mesenchymal transition |
| PDX | Patient-Derived Xenograft |
| TP-0903 | TP-0903 (drug candidate) |
| RNA | Ribonucleic acid |
| HDAC | histone deacetylase |
| DNA | Deoxyribonucleic Acid |
| DNMT | DNA methyltransferase |
| HMG-CoA | 3-Hydroxy-3-Methylglutaryl-Coenzyme A |
| RAS | Rat Sarcoma Virus Oncogene |
| RHO | Ras Homologous Protein |
| RAC | Ras-related C3 botulinum toxin substrate |
| GLI | Glioma-associated Oncogene |
| Hh | Hedgehog |
| ATPase | Adenosine Triphosphatase |
| AMPK | Adenosine Monophosphate Kinase |